OraSure Technologies to Webcast Annual Stockholders' Meeting

BETHLEHEM, Pa., May 15, 2002 (BW HealthWire) -- OraSure Technologies, Inc. (Nasdaq:OSUR), the market leader in oral fluid diagnostics, announced that it will webcast its 2002 Annual Meeting of Stockholders beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Monday, May 20, 2002.

The formal portion of the meeting will be immediately followed by a management presentation and a question and answer session. Persons accessing the webcast who desire to ask questions will be permitted to do so electronically by following the instructions on the Company's web site.

In order to access the webcast, please go to OraSure Technologies' web site, and click on the Investor Info link at the top of the page, at least ten minutes prior to the start of the webcast to register, download and install any necessary software. A replay of the webcast will be archived on OraSure Technologies' web site shortly after the webcast has ended and will be available for seven days.

The webcast will also be distributed over the CCBN (Corporate Communications Broadcast Network) Investor Distribution Network to both individual and institutional investors. Individual investors can access the webcast through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites on CCBN's Individual Investor Network. Institutional investors can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com).

    About OraSure Technologies

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies and diagnostic products, including immunoassays and other in vitro diagnostic tests and other medical devices. These products are sold in the United States and certain foreign countries to government agencies, clinical laboratories, physicians' offices, hospitals, commercial and industrial entities, and various distributors.

OraSure Technologies is the leading supplier of oral-fluid collection devices and assays to the life insurance industry and public health markets for the detection of antibodies to HIV-1. In addition, the Company supplies oral-fluid testing solutions for drugs of abuse testing. For more information on the Company, please go to www.orasure.com.

    www.orasure.com

CONTACT:          OraSure Technologies
                  Ronald H. Spair, 610/882-1820
                  Investorinfo@orasure.com


Today's News On The Net - Business Wire's full file
on the Internet with Hyperlinks to your home page.

Copyright (C) 2002 Business Wire.  All rights reserved.